Landscapes / Companies
Recursion Pharmaceuticals Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials · 6 in all
Trials
3 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Jun 2027Phase 1/2 trial completes | |||
| Next date | Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Familial Adenomatous Polyposis | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jul 2029Phase 1/2 trial completes | |||
| Next date | Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Unresectable, Locally Advanced and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2031Phase 1/2 trial completes | |||
| Next date | Jan 2031 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021